A Pragmatic Trial of Dietary Programs in People With Multiple Sclerosis

CompletedNot a drug-phase studyMS (type not specified)NCT02846558

What it found

Results posted, not judged

Results are posted in the registry, but without a statistical test of the main measure. See the numbers below.

What was tested

Treatment tested

  • Frequent Patient Interaction
  • Timing Restriction

Given to everyone in the trial

  • LoseIt! Smartphone Application

Results by group

Adherence

Baseline and 6 months

GroupValueIntervalNumber analysed
Calorie Restriction - Frequent Patient Communication2 Participants10
Calorie Restriction - Communication Standard of Care6 Participants9
Timing Restriction10 Participants12
No Diet Change12 Participants12

Calorie Restriction - Frequent Patient Communication

2

Calorie Restriction - Communication Standard of Care

6

Timing Restriction

10

No Diet Change

12

Values as posted on ClinicalTrials.gov. Outcomes measured differently across trials are not directly comparable.

Safety

GroupParticipants at riskSerious adverse eventsDeaths
Calorie Restriction - Frequent Patient Communication100 (0.0%)0
Calorie Restriction - Communication Standard of Care90 (0.0%)0
Timing Restriction120 (0.0%)0
No Diet Change120 (0.0%)0

As posted on ClinicalTrials.gov. Serious adverse events include any serious health event during the trial, whether or not the treatment caused it.

What it measured

Main measures

  • Adherence

    Baseline and 6 months

    Quality of life (reported by participants)

Other measures (7)

  • Body Mass Index (BMI)

    Baseline and 6 months

  • Weight Change

    Baseline and 6 months

  • Weight Change Among Adherent Participants

    Baseline and 6 months

    Quality of life (reported by participants)
  • Functional Assessment in MS Score

    Baseline and 6 months

    FatigueWalking and mobilityQuality of life (reported by participants)
  • Fatigue

    Baseline and 6 months

    FatigueQuality of life (reported by participants)
  • Sleep Quality

    Baseline and 6 months

    Mood and sleep
  • Self-esteem

    Baseline and 6 months

Who could take part

MS (type not specified) · 18 to 75

Show the full criteria

Inclusion criteria

* Body Mass Index (BMI) ≥ 25 kg/m\^2 for calorie restriction study * BMI \< 25 kg/m\^2, or ≥ 25 kg/m\^2 if participant was unwilling to enroll in calorie restriction study * Smartphone with the ability to download and use the LoseIt! application (calorie restriction only) * Smartphone with the ability to take and store photos (calorie timing only)

Exclusion criteria

* History of diabetes requiring medication * Currently pregnant or breastfeeding * History of an eating disorder * Currently taking warfarin * History of major surgery within past 3 months

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

This is a pragmatic, single-blinded randomized trial of improving adherence to dietary interventions in patients with MS who are receiving monthly natalizumab infusions.

Papers

Loading reviews and guidelines…

History

    1. Started

      Aug 2016

    2. Main results due

      Jun 2017

    3. Finished

      Jul 2017

    4. Results posted

      Jun 2018

    Assembled by software from public sources.